To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Economic Growth
Thursday 28th March 2024

Asked by: Simon Jupp (Conservative - East Devon)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, what the evidential basis is for his Department's tweet of 29 September 2023 that the UK was the fastest growing European G7 country since 2010.

Answered by Bim Afolami - Economic Secretary (HM Treasury)

The calculations underlying this statistic were based on public information available on the 29 September 2023, including quarterly GDP data published by the Office for National Statistics for the UK and OECD data for the remaining G7 European economies.

The data showed that cumulative GDP growth in the UK from the beginning of 2010 (change on 2009 Q4) through to 2023 Q2 of 24.2% was greater than that of France (16.4%), Italy (3.5%) and Germany (21.2%).


Written Question
NHS Walk-in Centres
Thursday 28th March 2024

Asked by: Simon Jupp (Conservative - East Devon)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will make it her policy to establish walk-in clinics in each Integrated Care Board; and what estimate she has made of the cost of doing so.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

The commissioning of establishing local services in the National Health Service is a matter for integrated care boards. The Government has no plans at this time to roll out hubs nationally.

Based upon current schemes which are either operational or under development in England, and assuming a facility floorplan of 3,000 square metres, the construction of a single walk-in hub service would cost £21.4 million in 2024/25 prices. Ongoing running costs for each building could be approximately £2 million to £2.3 million dependent on whether it was operational seven days a week and included wider primary care services such as dentistry.


Written Question
Income Tax: G7
Wednesday 27th March 2024

Asked by: Simon Jupp (Conservative - East Devon)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, what the evidential basis is for his Department's tweet of 6 January 2024 that the UK had the lowest effective average personal tax rate in the G7; and what the effective average personal tax rate is in each G7 country.

Answered by Nigel Huddleston - Financial Secretary (HM Treasury)

The Government is committed to rewarding hard work through a fair and simple tax system that is also competitive internationally. The Government is taking a responsible approach by delivering tax cuts within the fiscal rules.

The tweet of 6 January 2024 was based on the most recently published data from the OECD’s Taxing Wages 2023 publication. This shows the total personal tax liability divided by salary for a single employed individual with no children on average earnings for Germany (37.4%), Italy (28.8%), France (27.7%), Canada (25.6%), the US (24.8%) and Japan (22.3%). Following the 2p NICs cut made at Autumn Statement, the effective personal tax rate for an employee on £44,300 (the OECD’s figure for UK average earnings) reduced from 23.6% to 21.5%, which would be the lowest rate in the G7, according to the latest available OECD data. This has fallen to 20.1% following the further 2p NICs cut made at Spring Budget.


Speech in Commons Chamber - Tue 26 Mar 2024
Oral Answers to Questions

Speech Link

View all Simon Jupp (Con - East Devon) contributions to the debate on: Oral Answers to Questions

Speech in Commons Chamber - Tue 26 Mar 2024
Oral Answers to Questions

Speech Link

View all Simon Jupp (Con - East Devon) contributions to the debate on: Oral Answers to Questions

Division Vote (Commons)
25 Mar 2024 - Investigatory Powers (Amendment)Bill [Lords] - View Vote Context
Simon Jupp (Con) voted No - in line with the party majority and in line with the House
One of 262 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 171 Noes - 265
Division Vote (Commons)
25 Mar 2024 - Investigatory Powers (Amendment)Bill [Lords] - View Vote Context
Simon Jupp (Con) voted No - in line with the party majority and in line with the House
One of 251 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 39 Noes - 257
Division Vote (Commons)
25 Mar 2024 - Investigatory Powers (Amendment)Bill [Lords] - View Vote Context
Simon Jupp (Con) voted No - in line with the party majority and in line with the House
One of 261 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 171 Noes - 265
Division Vote (Commons)
25 Mar 2024 - Investigatory Powers (Amendment)Bill [Lords] - View Vote Context
Simon Jupp (Con) voted Aye - in line with the party majority and in line with the House
One of 252 Conservative Aye votes vs 0 Conservative No votes
Vote Tally: Ayes - 257 Noes - 38
Written Question
Sodium Valproate and Surgical Mesh Implants: Compensation
Wednesday 20th March 2024

Asked by: Simon Jupp (Conservative - East Devon)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published by the Patient Safety Commissioner on 7 February 2024, whether she has made an assessment of the potential implication for her policies of the provision of financial redress for people harmed by valproate and pelvic mesh.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course.